EASME

CardiacSense Ltd., founded in 2012 and based in Caesarea, Israel, develops innovative medical wearable devices aimed at monitoring heart arrhythmias and other critical health metrics. The company's FDA and CE certified medical watches and wristbands provide continuous, long-term, ambulatory, and non-invasive monitoring of vital functions, including heart rate, pulse rate, respiratory rate, core temperature, oxygen saturation, and blood pressure. Utilizing advanced PPG technology, CardiacSense's devices enable accurate real-time diagnostics for various medical conditions such as atrial fibrillation, hypertension, chronic obstructive pulmonary disease, heart failure, sleep apnea, and infections like COVID-19. By focusing on the prevention and early detection of cardiac events, CardiacSense aims to enhance healthcare delivery and improve patient outcomes.

mDurance is a digital health company that develops wearable electromyography (EMG) technology to assess and monitor muscle health for professionals in physical health, sports, and wellness. Its system combines a lightweight EMG sensor, Bluetooth-enabled device, mobile and web applications, cloud storage, and real-time data analytics to provide objective muscle data. The solution enables verification of muscle health through pattern analysis, real-time biofeedback on resistance, strength, and fatigue, and detection of muscle asymmetries to support rehabilitation and performance optimization. By synchronizing EMG data with video feedback, the platform helps healthcare and sports professionals monitor neuromuscular function, improve patient or athlete engagement, and guide evidence-based decisions without relying on subjective assessments.

Hedia is a health technology company that has created an artificial intelligence-based application aimed at assisting individuals with type 1 and type 2 diabetes. The application functions as a personal diabetes assistant, monitoring users' carbohydrate intake and exercise habits to provide tailored insulin recommendations. By analyzing individual patterns and behaviors, Hedia's solution aims to simplify daily management of diabetes, enhancing the quality of life for its users through informed insulin treatment.

MyoSwiss is a Swiss medtech company that develops robotic and textile technology to help people with muscle weakness regain mobility and independence. The company manufactures the Myosuit and Myofit training devices used in rehabilitation and physiotherapy to improve walking and running ability. It offers individualized training plans, intensive and activity-based training, and performance tracking, along with a multifunctional training device that provides an additional layer of muscle support for mobility-impaired patients. Founded in 2017, the company is based in Zurich, Switzerland.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

liberDi is an Israeli company that specializes in developing portable automatic peritoneal dialysis systems for patients with end-stage renal disease. The company has created a comprehensive Digital Dialysis Clinic that enables patients to manage their own dialysis care with the assistance of an Intelligent Dialysis Assistant and remote medical supervision. This innovative self-care system allows patients to perform dialysis conveniently from various locations, such as their homes or while traveling, thereby enhancing their quality of life. Founded in 2014, liberDi aims to transform the traditional dialysis model by providing a safe, patient-friendly alternative to in-clinic care. The company's technology not only empowers patients but also helps clinics optimize their operations, improve service quality, and reduce costs, establishing a holistic platform for renal patients and their caregivers.

Nateo Healthcare is a Toulouse, France-based medical technology company that designs, develops, and manufactures connected devices and software for obstetrics and gynecology. Founded by obstetricians, gynecologists and medical technology specialists, the company focuses on portable fetal monitoring solutions, including compact mobile fetal heart and uterine activity monitoring systems, and remote patient monitoring for maternity care. Its products enable continuous fetal heart rate and uterine activity assessment, support telemonitoring for home use or hospital settings, and aim to optimize bed utilization in maternity wards while enhancing patient well-being through more flexible care. By integrating wireless connections and real-time data, Nateo Healthcare seeks to provide clinicians with mobile, connected CTG monitoring capabilities and to expand access to monitoring in hospitals and at home.

Cardioset Medical is a group of scientists and business people who strive to make a life-changing impact on patients suffering from heart failure lung edema. With over 15 years of research and development we now have the solution that can literally revolutionize millions of HF patients' lives by enabling them to self-monitor their lung edema state and detect small changes at an even earliest stage.

Capitainer is a Swedish medical device company that develops volumetric blood collection devices for fixed-volume dried blood spots collected at home. The device enables patients to remotely collect a predefined blood volume, which can be mailed to a laboratory for analysis. The technology aims to reduce patient travel and healthcare resources required for blood sampling, while delivering improved accuracy over conventional methods and offering cost and environmental savings for healthcare providers handling large volumes of samples. Founded in 2016 and based in Stockholm, Capitainer focuses on enabling convenient, safe, and reliable remote blood collection for quantitative testing.

Lucine is a company focused on improving patient health, primarily targeting pain management. It develops a mobile health application that offers a digital therapeutic solution designed to relieve pain within five minutes through analgesic neurostimulation. The application employs advanced algorithms to measure and analyze pain by utilizing facial, vocal, and postural recognition. This technology allows for personalized treatment, as it instantly adapts to each patient's specific needs. The application provides a variety of techniques to alleviate pain symptoms, including exercises, relaxation methods, art therapy, and meditation, empowering patients with chronic pain to manage their conditions effectively from home.

Thermetrix Ltd. is a company based in Abercynon, United Kingdom, that specializes in the design and manufacture of hardware and software for personal healthcare systems and devices. Founded in 2016, the company offers a range of services, including design, software development, and research and testing, aimed at enhancing personal healthcare solutions.

Picterus is developing an app to diagnose jaundice in newborns, aiming to reduce the global infant mortality associated with this condition. The platform uses a patented color calibration card and smartphone camera for accurate image capture, providing healthcare professionals and caregivers with a reliable tool for early detection and timely intervention.

Probiomedica is a company focused on developing innovative biomedical devices that integrate engineering, biology, photonics, and robotics for health and personal care applications. The company specializes in creating small swallowable capsules designed to emit light at specific wavelengths, utilizing the principles of Photodynamic therapy. This technology aims to enhance the photo-killing of harmful bacteria such as Helicobacter pylori, which is associated with conditions like gastritis, peptic ulcers, and gastric cancer. By employing these advanced photonic techniques, Probiomedica seeks to offer effective treatments that minimize reliance on pharmaceuticals and reduce the risk of drug-related side effects, thereby improving patient outcomes in the realm of gastrointestinal health.

eLive Ecosystem specializes in developing innovative solutions aimed at preventing long-term diseases through advanced technology. The company has created an artificial intelligence-based medical device specifically designed for the self-measurement of sleep apnea, addressing diagnostic gaps and enhancing treatment monitoring. By integrating medicine, genomics, and advanced sensor technology, eLive aims to alleviate the pressures on healthcare systems caused by demographic changes and aging populations. Their platform focuses on enabling healthcare professionals to efficiently and cost-effectively manage disease prevention and treatment, ultimately improving patient outcomes on a global scale.

Founded in 2014 and headquartered in Jena, Germany, Preventicus develops certified medical device software for smartphones and smartwatches. Its primary product, Preventicus Heartbeats, identifies atrial fibrillation for stroke prevention by analyzing patients' vital parameters, enabling early detection of lifestyle-related illnesses.

Airofit is a Danish company that has developed a personal training system aimed at strengthening respiratory muscles and improving breathing. Originally designed for medical applications, particularly for patients with lung conditions like asthma and bronchitis, Airofit's equipment focuses on training the diaphragm and intercostal muscles. The system has proven to be effective not only for its initial target demographic but also for athletes seeking to enhance their endurance and respiratory strength. Additionally, singers and musicians who play wind instruments benefit from increased respiratory capacity and coordination, leading to improved tone and sound quality. By providing a means to enhance respiratory performance, Airofit offers a valuable solution for both health and performance enhancement.

liberDi is an Israeli company that specializes in developing portable automatic peritoneal dialysis systems for patients with end-stage renal disease. The company has created a comprehensive Digital Dialysis Clinic that enables patients to manage their own dialysis care with the assistance of an Intelligent Dialysis Assistant and remote medical supervision. This innovative self-care system allows patients to perform dialysis conveniently from various locations, such as their homes or while traveling, thereby enhancing their quality of life. Founded in 2014, liberDi aims to transform the traditional dialysis model by providing a safe, patient-friendly alternative to in-clinic care. The company's technology not only empowers patients but also helps clinics optimize their operations, improve service quality, and reduce costs, establishing a holistic platform for renal patients and their caregivers.

Resani is a developer of innovative hand sanitizing technology aimed at enhancing hand hygiene compliance and ultimately saving lives. The company offers a solution that integrates an automatic hand sanitizer with a disinfection cartridge and user monitoring technology. This combination not only promotes frequent use but also utilizes advanced statistical data modeling to provide insights into hand hygiene practices. By visualizing compliance in real-time, Resani enables users to make informed decisions and achieve predictable outcomes in infection control. The design of the technology is both attractive and functional, ensuring that it is accessible, reliable, and sustainable, thereby significantly improving hand hygiene practices in various settings.

Kamleon is a developer of innovative physiological technology focused on enhancing health and well-being through advanced monitoring solutions. The company has created a cloud-based digital platform that integrates various tools and features, allowing users to seamlessly monitor their health in real time. By transforming the bathroom into a smart environment for health assessment, Kamleon enables individuals to analyze urine and gain insights into their overall health status. This approach democratizes health monitoring, making it accessible and straightforward for users to understand and manage their well-being.

RaccoonCare is a wellness corporate tool that helps companies to make their employees efficient and healthy by keeping them physically active on a daily basis. It's like a fitness app that is evidence based and will help you to be active every day. Our app suggests when to take active breaks, what elementary exercises can be done right at the workplace, what to do in case of back or neck pain, etc. And all this is managed by HR, which can create individual and collective challenges for team cohesion and increasing their activity and efficiency. Our technology works on the basis of medical protocols, evidence based and is validated by American and German physiotherapists.

YuScale is a technology company that specializes in providing information services focused on determining the nutritional composition of meals. Their primary offering includes an app and online service designed to quickly and securely analyze the nutritional content of a complete meal, with a particular emphasis on carbohydrates for individuals managing diabetes. The platform helps users understand the health quotient of their food intake, enabling those with specific dietary requirements to effectively monitor and manage their diets.

Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.

Breathe ilo is an innovative Austrian startup that specializes in fertility tracking through breath analysis. Founded in 2019 by Professor Dr. Ludwig Wildt and Dr. Horst Rüther, the company has developed the world's first handheld device that analyzes CO2 saturation in a woman's breath to accurately identify her ovulation pattern and fertile window. This user-friendly technology is synchronized with a mobile application, allowing women to monitor their menstrual cycles with precision at any time of day. Breathe ilo aims to empower women by enhancing their understanding of their bodies and breaking the stigma surrounding discussions about conception and cycle tracking. Led by Co-CEOs Lisa Krapinger-Rüther and Wernhard Berger, the company is committed to promoting women's health and well-being globally.

Salumedia Labs is a developer of evidence-based digital therapeutics focused on enhancing adherence to healthy lifestyles and medical treatments. The company utilizes behavioral science, artificial intelligence, and digital engagement techniques to create products that empower patients and support their lifestyle changes. In 2021, Salumedia Labs was acquired by Adhera Health, Inc., further expanding its reach and impact in the healthcare sector.

Gnubiotics Sciences SA is a biotechnology company based in Epalinges, Switzerland, focused on developing microbiome-modulating products for both humans and animals. Founded in 2016, the company specializes in producing glycans that enhance microbiome diversity and promote gut health. One of its notable products, AMObiomeTM, serves as a natural ingredient aimed at improving microbiome balance and overall wellness. Gnubiotics is also engaged in creating functional and structural mimics of Human Milk Oligosaccharides, which are designed to replicate the beneficial properties of breast milk. These innovations are intended to prevent infections, combat diet-induced obesity, and support immune health by nurturing a diverse microbiome.

Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Thomas Medical, Inc. is a manufacturer of medical devices and accessories specifically designed for women's health. Established in 2004 and headquartered in Indianapolis, Indiana, the company produces a range of single-use products, including catheters, procedure trays, uterine manipulators, injectors, endometrial samplers, intrauterine insemination catheters, and electrodes. These products are utilized in various healthcare settings, such as hospitals, surgery centers, radiology/imaging centers, fertility clinics, and OB/GYN practices worldwide. As a subsidiary of MedGyn Products Inc. since September 2020, Thomas Medical is committed to providing high-quality instruments at competitive prices, catering to the diverse needs of professionals in the gynecology and fertility markets.

PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.

Remod is a Berlin-based startup focused on rehabilitation technology. The company has developed a motion-sensing device that aims to correct postural defects. This innovative device utilizes IoT-assisted electronic biofeedback to monitor posture, facilitating communication between the brain and the musculoskeletal system. By doing so, it enables patients suffering from hemiparesis to work towards regaining a normal gait, thereby improving their overall mobility and quality of life.

SocialDiabetes is a digital health company focused on improving the management and treatment of type 1 and type 2 diabetes. The company aims to revolutionize diabetes care by moving away from traditional methods, such as paper logbooks, to a technology-driven approach that enhances patient experience. SocialDiabetes offers a software platform that includes a mobile app for patients and a web interface for healthcare professionals, allowing for real-time engagement and monitoring. By utilizing advanced algorithms, the platform provides personalized insights and actionable data, empowering patients to take control of their health and enabling healthcare providers to deliver efficient, high-quality care remotely. With diabetes affecting over 400 million people globally and imposing significant economic burdens on healthcare systems, SocialDiabetes seeks to transform diabetes management through innovative technological solutions, fostering autonomy and improving overall health outcomes for individuals with diabetes.

Oblow is a natural solution to treat stress by learning breathing techniques thanks to a simple device that is synchronized with the Oblow application, allowing the user to track their stress peaks and see the results of the exercises performed.

SmartLife is a specialist in smart garment technology. It has developed innovative, patented textile sensors, electronics and firmware that are capable of detecting the body’s biophysical signals, and delivering actionable insight to users via mobile apps.

Sense4Care, established by researchers from the Technical Research Centre for Dependency Care and Autonomous Living (CETpD) at Universitat Politècnica de Catalunya (UPC), specializes in developing medical devices for individuals with chronic diseases and fragility issues. The company designs, manufactures, and markets wearable devices that monitor and record movement patterns, falls, postures, and motor symptoms, aiding healthcare professionals in patient symptom tracking and care.

Concilio is a digital health platform headquartered in Paris, France, focused on enhancing access to healthcare and preventive services. The company develops a healthcare service platform that assesses and improves personal health by providing tailored healthcare recommendations and medical consultations. Users benefit from personalized insights and can connect with appropriate healthcare professionals for curated advice. Concilio aims to deliver reliable health information, facilitating quick access to specialists suited to individual health needs.

Decodeon empowers people to cure their own disease by offering personal insights and enabling them to be part of medical research. Currently, 80% of all clinical trials are delayed or cancelled. By finding and connecting matching participants to clinical trials, the company help to speed up the development of medicine. Its goal is to advance knowledge and ultimately help people with a rare disease to lead better lives.

Carbiotix is a pre-clinical stage therapeutics company based in Sweden that specializes in gut health testing and microbiome modulators to address chronic and metabolic diseases. Founded in 2014, Carbiotix emerged from four years of research at Lund University and the Antidiabetic Food Centre. The company has developed a low-cost gut health testing platform, which was launched in 2018, and initiated a significant gut health study involving 600 participants. Carbiotix's product offerings include OneGut, MonthGut, LinkGut, and HealthGut, all designed to harness the potential of the gut microbiome. The company aims to create innovative microbiome modulators utilizing its proprietary soluble fiber, isolated strains, and novel delivery mechanisms, thereby enhancing therapeutic development activities in line with its long-term strategy.

CosmEthics develops a mobile application that educates consumers about cosmetic ingredient safety and helps them choose safer products. By scanning product barcodes, the app cross-references ingredients with medical research on toxins and allergens and provides a rapid toxicity screening of INCI ingredients to highlight health hazards and potential safer alternative options.

Nox Health is a global leader in sleep health, dedicated to improving lives through innovative, people-centered solutions addressing the worldwide sleep epidemic. As the world's leading provider of sleep medical technology, Nox Health eliminates common pain points in sleep testing and delivers high-quality data insights for clinicians. Its SleepCharge platform in the United States enables comprehensive sleep healthcare access, benefiting over 2 million individuals and hundreds of thousands of employees.

Salumedia Labs is a developer of evidence-based digital therapeutics focused on enhancing adherence to healthy lifestyles and medical treatments. The company utilizes behavioral science, artificial intelligence, and digital engagement techniques to create products that empower patients and support their lifestyle changes. In 2021, Salumedia Labs was acquired by Adhera Health, Inc., further expanding its reach and impact in the healthcare sector.

Lifecare AS is a privately owned company based in Bergen, Norway, founded in 2006. The company specializes in the research and development of medical sensors aimed at health monitoring. Its primary focus is on creating innovative tools for monitoring glucose levels, marketed under the SENCELL brand. Lifecare AS conducts its research and development activities through various European affiliates and is funded by private investors as well as governmental grants.

Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Kleinklein researches chronic pain and provides real solutions, therapies, courses, and workshops to help people understand their pain. We help them and their spouses take steps that reduce the frequency and severity of pain. Kleinklein knows that chronic pain can be debilitating. Although often unrelated to a medical condition, the pain is perceived, real, persistent, and can be seen in the MRI. Pain can be visceral or somatic, nociceptive or neuropathic, and deeply affects lives.

Nemo Healthcare is a company focused on non-invasive electrophysiological fetal monitoring. Originating from Eindhoven University of Technology in collaboration with Máxima Medical Center in Veldhoven, the company develops diagnostics technology that records electrophysiological signals non-invasively from the maternal abdomen. Its objective is to provide obstetricians, gynecologists and midwives with tools to assess fetal well-being with maximum safety and comfort for mother and unborn child, enabling caregivers to detect obstetric problems promptly and improve neonatal outcomes. The technology aims to offer monitoring that is non-invasive, reducing discomfort for both mother and fetus and supporting safer obstetric care.

Access for Life is a medical device company focused on vascular access solutions for patients requiring repetitive venous access, including those undergoing hemodialysis and cancer treatment. The firm develops subcutaneously implanted devices that attach to a vessel wall to provide a fixed puncture site for repeated needle insertions, using sensor-equipped components to guide needle placement in real time. The aim is to reduce complications such as hematomas, thrombosis, and stenosis, improve long-term access patency, lower infection risk, and potentially enhance monitoring and personalized care, while lowering healthcare costs. The JEM system, affixed to the vessel, targets dialysis fistulas and, in cancer patients, upper-arm veins to avoid chest wall issues. The overall objective is safer, more durable venous access and reduced patient morbidity.

Second Nature is a London-based company that offers online behavioral change programs designed to help individuals manage their health, particularly those at risk of type 2 diabetes. Founded in 2013, the company provides a smartphone application that coaches and motivates users to adopt healthier lifestyles. Through its platform, users can sign up for various programs, track their progress, and ultimately graduate to maintain their health improvements. Formerly known as Our Path Ltd, the company rebranded to Second Nature in February 2020, reflecting its commitment to fostering lasting lifestyle changes for its users.

COPCAR is an ECG monitoring system and real-time alert that drastically reduces response times to a cardiovascular accident. COPCAR is designed for people who have suffered or are at risk of suffering from some type of cardiovascular anomaly. Alterations such as severe arrhythmias or myocardial infarction are detected and attended in a record time, increasing the probability of survival.

Talemnology is a healthcare technology company that specializes in developing mobile tools to empower chronic patients in managing their illnesses. The company focuses on creating wearable biosensors tailored to the specific needs of patients, particularly those with conditions such as congestive heart failure and those who rely on pacemakers. By providing these advanced mobile systems, Talemnology enables patients to take an active role in monitoring and controlling their health, addressing gaps in the healthcare sector and enhancing patient engagement in their disease management.

Psyomics specializes in the development of proteomic diagnostics aimed at improving early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers web-based assessment triage designed to facilitate diagnostic and pathway prediction for mental health conditions. By integrating digital profiling with cutting-edge biological research, Psyomics enhances diagnostic accuracy and supports primary care practitioners in effectively managing their patients' mental health needs. This innovative approach digitally replicates a psychiatric assessment at the initial point of contact, thereby enabling patients to achieve better recovery outcomes from mental health disorders.

Líder Doctor offers innovative health services that provide quality health. Líder Doctor is born, a company formed by a multidisciplinary team of doctors, pharmacists, biologists, physiotherapists and health specialists. The goal of Leader Doctor is to make accessible to our clients, in a simple and practical way, the advances and innovations that are being made in the field of health, whatever the place of residence of the person concerned, thus avoiding displacements and delays in the time. Leader Doctor is commitment for quality also understood as a continuous process of improving the service to their customers. This commitment involves the managers, employees and collaborators, the administrative staff and the medical personnel that collaborates with the company and is present in the philosophy and in all the processes.

Salumedia Labs is a developer of evidence-based digital therapeutics focused on enhancing adherence to healthy lifestyles and medical treatments. The company utilizes behavioral science, artificial intelligence, and digital engagement techniques to create products that empower patients and support their lifestyle changes. In 2021, Salumedia Labs was acquired by Adhera Health, Inc., further expanding its reach and impact in the healthcare sector.

Salumedia Labs is a developer of evidence-based digital therapeutics focused on enhancing adherence to healthy lifestyles and medical treatments. The company utilizes behavioral science, artificial intelligence, and digital engagement techniques to create products that empower patients and support their lifestyle changes. In 2021, Salumedia Labs was acquired by Adhera Health, Inc., further expanding its reach and impact in the healthcare sector.

Founded in Berlin in 2011 by doctors, scientists, and industry pioneers, Ada Health is a global health company dedicated to creating new possibilities for personal health management. Its core system connects medical knowledge with intelligent technology to empower individuals to actively manage their health and assist medical professionals in delivering effective care.

Radisens Diagnostics develops digital diagnostic devices for point-of-care testing. Their platform integrates immunochemistry, clinical chemistry, and haematology assays onto multiplexed test panels using just a drop of blood, providing instant results. Initially focusing on chronic disease panels such as diabetes and heart disease, the company aims to expand into cell counting, cardiac, and oncology targets.

Sword Health specializes in digital health solutions for physical rehabilitation. It employs artificial intelligence to deliver personalized care globally, enabling patients to perform interactive exercises at home under remote physiotherapist supervision.

ptTheragnostic B.V. is a biotechnology company based in Maastricht, the Netherlands, specializing in genomics-based analysis to optimize radiation treatment for cancer and predict the risk of chronic diseases. Established in 2014 as a spin-off from the Maastro clinic and Maastricht University Medical Center, the company operates as a subsidiary of DNAmito Inc. Following its acquisition in 2015, ptTheragnostic has developed two significant assets: MitoTx™, a mitochondrial DNA assay that predicts the risk of radiation-induced toxicity in patients undergoing radiotherapy, and PRODECIS™, a clinical decision support system designed to identify suitable candidates for proton therapy. By leveraging its unique multidisciplinary team of clinicians, physicists, and software developers, ptTheragnostic aims to deliver more effective and individualized radiation therapy solutions for cancer patients. The collaboration with Maastro clinic and Maastricht University Medical Center also enhances the company's innovation potential through access to cutting-edge research and data analysis capabilities.

Sense4Care, established by researchers from the Technical Research Centre for Dependency Care and Autonomous Living (CETpD) at Universitat Politècnica de Catalunya (UPC), specializes in developing medical devices for individuals with chronic diseases and fragility issues. The company designs, manufactures, and markets wearable devices that monitor and record movement patterns, falls, postures, and motor symptoms, aiding healthcare professionals in patient symptom tracking and care.

Dr. Niine Nahakliinik provides early detection, diagnosis, and treatment of melanoma and skin cancer. It also offers efficient and affordable diagnostics and treatment for skin disorders. Its portfolio of beauty care offers patients modern minimally invasive procedures and plastic surgeries to improve their appearance and well-being. Niine Nahakliinik uses all the newest technologies to assure that its dermatologists, oncologists, and surgeons can solve every problem precisely and quickly.

Nox Health is a global leader in sleep health, dedicated to improving lives through innovative, people-centered solutions addressing the worldwide sleep epidemic. As the world's leading provider of sleep medical technology, Nox Health eliminates common pain points in sleep testing and delivers high-quality data insights for clinicians. Its SleepCharge platform in the United States enables comprehensive sleep healthcare access, benefiting over 2 million individuals and hundreds of thousands of employees.

Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, specializing in the design and manufacture of innovative monitoring devices. The company offers a range of products, including the PRIME device, which utilizes wireless sensors for vital sign monitoring and data analysis, allowing clinicians to remotely visualize, transmit, and store patient data. Additionally, Rinicare has developed PRIME IoT, which facilitates the transmission of vital sign data to compatible devices through healthcare application software. The company also focuses on patient safety with its SAFE system, a falls detection and prevention solution that employs thermal imaging sensors and intelligent algorithms to monitor patients' positions in bed, alerting clinicians to potential fall risks. Through these technologies, Rinicare aims to enhance patient care by providing real-time insights that support informed decision-making in clinical settings. Established in 2002, Rinicare continues to innovate within the healthcare sector.

PubGene develops bioinformatics solutions for life sciences, focusing on organizing information relevant to drug development, disease prevention, diagnostics, and human health. Its core product is Coremine Medical, a software-as-a-service platform offering access to vast amounts of medical information from high-quality sources like MEDLINE and PubMed. Additionally, PubGene offers COREMINE Oncology for analyzing complex cancer-specific mutational profiles.

SelfDiagnostics is a company specializing in home medical testing that leverages advanced molecular diagnostic technology, particularly through the application of polymerase chain reaction (PCR). Its innovative products empower individuals to take charge of their health by enabling accurate self-diagnosis for various conditions, including sexually transmitted diseases and respiratory infections. By providing laboratory-grade precision in a user-friendly format, SelfDiagnostics aims to facilitate early detection and treatment of health issues, responding to the growing demand for patient autonomy in healthcare. The company’s flagship product, the STD Multitest, is designed for widespread distribution, with plans to expand its portfolio to include tests for other diseases, such as influenza and various blood-borne pathogens. Through this approach, SelfDiagnostics is at the forefront of next-generation molecular diagnostics, bringing sophisticated medical testing directly to patients’ homes.

Microphyt is a company focused on researching, developing, producing, and marketing natural algae-based products. It specializes in creating bioactive dietary supplements aimed at promoting weight loss and supporting brain health. The company utilizes an industrial-scale supply of microalgae biomass and extracts, ensuring the preservation of cell integrity while achieving commercial quantities of slow-growing or biofilm-forming species. This approach enables Microphyt to effectively cater to the demands of healthcare industries, particularly in the personal care and food sectors.

Dr. Dolhay is an intimate hygiene and disease prevention platform.

Medtep Inc., established in 2011 and headquartered in Redwood City, California, specializes in developing medical software solutions that connect healthcare professionals and patients. Its core products are uClinics and uPatient, which together facilitate patient care and health management. uClinics is an electronic health record system that enables healthcare professionals to prescribe and assess patients, while uPatient empowers patients to understand and monitor their health and treatment. These solutions are accessible via computer, tablet, or smartphone devices. Medtep serves a diverse range of clients, including medical societies, pharmaceutical companies, clinical laboratories, and insurance companies, among others. It focuses on disease prevention through monitoring and understanding of patients' life habits, aggregating and merging data from various sources to provide comprehensive, patient-friendly information. By upgrading monitoring processes and encouraging patient engagement, Medtep helps patients take a more active role in their own health and treatment.

ScanZ is an easy-to-use handheld device with advanced imaging and algorithms to identify, track, and quantify acne. The imaging device connects with a tablet/mobile application to monitor and analyse acne conditions and severity. ScanZ enables more accurate, objective diagnosis, tracking and monitoring at hospitals, clinics, or remotely from home. In the Healthcare industry, digital healthcare solutions will become vital in order to ensure a sustainable and efficient health system in both a time and cost effective manner. ScanZ aims to significantly contribute in creating innovative and sustainable principles in the Healthcare market by improving the quality of life for acne sufferers and working conditions for medical professionals. ScanZ is an innovative digital skin-care solution for acne sufferers, dermatologists, and medical practitioners, applying new sets of rules, values and model to the health-care market. Up to now, acne assessment was only possible visiting dermatologist and traditional acne assessment was a time consuming and costly procedure. Today, with ScanZ’s proprietary assessment, there are better, more objective alternatives to help the millions of acne sufferers and thousands of dermatologists. The ScanZ team is currently refining the technical readiness level to be market ready enabling the device to be clinically and commercially qualified for launch. ScanZ will be available commercially at the end of the Phase 2 grant as a medically certified, IP protected user-centric designed system to be sold to hospitals, practitioners and the community.

Nemo Healthcare is a company focused on non-invasive electrophysiological fetal monitoring. Originating from Eindhoven University of Technology in collaboration with Máxima Medical Center in Veldhoven, the company develops diagnostics technology that records electrophysiological signals non-invasively from the maternal abdomen. Its objective is to provide obstetricians, gynecologists and midwives with tools to assess fetal well-being with maximum safety and comfort for mother and unborn child, enabling caregivers to detect obstetric problems promptly and improve neonatal outcomes. The technology aims to offer monitoring that is non-invasive, reducing discomfort for both mother and fetus and supporting safer obstetric care.

Oxitone Medical is a medical device company that has developed a wrist-based pulse oximetry continuous monitoring platform for home care and remote patient management. The FDA-cleared solution uses AI-assisted analytics to turn continuous data into personalized therapeutic guidance without requiring a fingertip probe, enabling efficient remote monitoring of high-risk patients. The system is deployed in more than ten countries and supports continuous data collection for hyper-personalized interventions, with partnerships including Ascom for monitoring COVID-19 patients.